ONO 8815Ly
Alternative Names: ONO 8815Latest Information Update: 26 May 2010
At a glance
- Originator Ono Pharmaceutical
- Class Small molecules
- Mechanism of Action Dinoprostone agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Preterm labour